Systemic levels of TNF-a, IL-1b, IL-6, and CRP are elevated in both type 1 and type 2 diabetes patients (36, 37), which is a result of the chronic activation of pro-inflammatory pathways within insulin-target cells (38). This evidence concerns the gene TNF and type 2 diabetes mellitus.